Back to Search Start Over

Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.

Authors :
Armaiz-Pena, Gustavo
Flores, Shahida K
Cheng, Zi-Ming
Zhang, Xhingyu
Esquivel, Emmanuel
Poullard, Natalie
Vaidyanathan, Anusha
Liu, Qianqian
Michalek, Joel
Santillan-Gomez, Alfredo A
Liss, Michael
Ahmadi, Sara
Katselnik, Daniel
Maldonado, Enrique
Salgado, Sarimar Agosto
Jimenez, Camilo
Fishbein, Lauren
Hamidi, Oksana
Else, Tobias
Lechan, Ron
Source :
Journal of Clinical Endocrinology & Metabolism; Jan2021, Vol. 106 Issue 1, pe350-e364, 15p
Publication Year :
2021

Abstract

<bold>Purpose: </bold>This work aimed to evaluate genotype-phenotype associations in individuals carrying germline variants of transmembrane protein 127 gene (TMEM127), a poorly known gene that confers susceptibility to pheochromocytoma (PHEO) and paraganglioma (PGL).<bold>Design: </bold>Data were collected from a registry of probands with TMEM127 variants, published reports, and public databases.<bold>Main Outcome Analysis: </bold>Clinical, genetic, and functional associations were determined.<bold>Results: </bold>The cohort comprised 110 index patients (111 variants) with a mean age of 45 years (range, 21-84 years). Females were predominant (76 vs 34, P < .001). Most patients had PHEO (n = 94; 85.5%), although PGL (n = 10; 9%) and renal cell carcinoma (RCC, n = 6; 5.4%) were also detected, either alone or in combination with PHEO. One-third of the cases had multiple tumors, and known family history was reported in 15.4%. Metastatic PHEO/PGL was rare (2.8%). Epinephrine alone, or combined with norepinephrine, accounted for 82% of the catecholamine profiles of PHEO/PGLs. Most variants (n = 63) occurred only once and 13 were recurrent (2-12 times). Although nontruncating variants were less frequent than truncating changes overall, they were predominant in non-PHEO clinical presentations (36% PHEO-only vs 69% other, P < .001) and clustered disproportionately within transmembrane regions (P < .01), underscoring the relevance of these domains for TMEM127 function. Integration of clinical and previous experimental data supported classification of variants into 4 groups based on mutation type, localization, and predicted disruption.<bold>Conclusions: </bold>Patients with TMEM127 variants often resemble sporadic nonmetastatic PHEOs. PGL and RCC may also co-occur, although their causal link requires further evaluation. We propose a new classification to predict variant pathogenicity and assist with carrier surveillance. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0021972X
Volume :
106
Issue :
1
Database :
Complementary Index
Journal :
Journal of Clinical Endocrinology & Metabolism
Publication Type :
Academic Journal
Accession number :
147866908
Full Text :
https://doi.org/10.1210/clinem/dgaa741